In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
July 23rd, 2004 | 11 | Yes |
Popular Name: 3,4-Dihydro-2(1H)-quinolinone 3,4-Dihydro-2(1H)-quinolinone
"3,4-Dihydro-2(1H)-quinolinone, 97%"
1,2,3,4-Tetrahydroquinolin-2-one
2-Oxo-1,2,3,4-tetrahydroquinoline
3,4-Dihydro-(1H)-quinolin-2-one
3,4-Dihydro-2(1H)-quinolinone, 98%
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 1.63 | 3.68 | -6.68 | 1 | 2 | 0 | 29 | 147.177 | 0 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
Mp [°C] | 165 - 167 | Acros Organics |
Melting_Point | 165-167? | Alfa-Aesar |
MP | 165-167° | Oakwood Chemical |
MP | 166 - 167 | Enamine Building Blocks |
MP | 166...167 | Enamine Building Blocks |
purity | 9.500000000000000e+001 | Enamine Building Blocks Enamine Building Blocks |
Purity | 95% | Fluorochem |
Purity | 98% | Fluorochem |
H phrase | H312: Harmful in contact with skin | Acros Organics |
H phrase | H315: Causes skin irritation; H319: Causes serious eye irritation; H335: May cause respiratory irritation | Acros Organics |
Warnings | IRRITANT | Matrix Scientific |
P phrase | P280: Wear protective gloves/protective clothing/eye protection/face protection | Acros Organics |
P phrase | P280: Wear protective gloves/protective clothing/eye protection/face protection; P302 + P352: IF ON SKIN: Wash with plenty of soap and water; P261: Avoid breathing dust/fume/gas/mist/vapors/spray; P302 + P352: IF ON SKIN: Wash with plenty of soap and wate | Acros Organics |
R phrase | R20/21/22: Harmful by inhalation, in contact with skin and if swallowed. | Acros Organics |
R phrase | R36/37/38: Irritating to eyes, respiratory system and skin. | Acros Organics |
S phrase | S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. | Acros Organics |
S phrase | S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.; S36/37/39: Wear suitable protective clothing, gloves and eye/face protection. | Acros Organics |
Hazard | XI: Irritant | Acros Organics |
Hazard | XN: Harmful | Acros Organics |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
MK11-1-E | MAP Kinase P38 Beta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1 | 1.15 | Binding ≤ 10μM |
MK12-1-E | MAP Kinase P38 Gamma (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1 | 1.15 | Binding ≤ 10μM |
MK13-1-E | MAP Kinase P38 Delta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1 | 1.15 | Binding ≤ 10μM |
MK14-2-E | MAP Kinase P38 Alpha (cluster #2 Of 3), Eukaryotic | Eukaryotes | 1 | 1.15 | Binding ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
MK14_HUMAN | Q16539 | MAP Kinase P38 Alpha, Human | 0.74 | 1.16 | Binding ≤ 1μM |
MK11_HUMAN | Q15759 | MAP Kinase P38 Beta, Human | 0.74 | 1.16 | Binding ≤ 1μM |
MK13_HUMAN | O15264 | MAP Kinase P38 Delta, Human | 0.74 | 1.16 | Binding ≤ 1μM |
MK12_HUMAN | P53778 | MAP Kinase P38 Gamma, Human | 0.74 | 1.16 | Binding ≤ 1μM |
MK14_HUMAN | Q16539 | MAP Kinase P38 Alpha, Human | 0.74 | 1.16 | Binding ≤ 10μM |
MK11_HUMAN | Q15759 | MAP Kinase P38 Beta, Human | 0.74 | 1.16 | Binding ≤ 10μM |
MK13_HUMAN | O15264 | MAP Kinase P38 Delta, Human | 0.74 | 1.16 | Binding ≤ 10μM |
MK12_HUMAN | P53778 | MAP Kinase P38 Gamma, Human | 0.74 | 1.16 | Binding ≤ 10μM |
Description | Species |
---|---|
activated TAK1 mediates p38 MAPK activation | |
Activation of PPARGC1A (PGC-1alpha) by phosphorylation | |
Activation of the AP-1 family of transcription factors | |
ADP signalling through P2Y purinoceptor 1 | |
CDO in myogenesis | |
DSCAM interactions | |
ERK/MAPK targets | |
KSRP destabilizes mRNA | |
NOD1/2 Signaling Pathway | |
Oxidative Stress Induced Senescence | |
p38MAPK events | |
Platelet sensitization by LDL | |
VEGFA-VEGFR2 Pathway |